Reviews evidence with regard to the characteristics and properties of the EMLA cream. Helps the practitioner understand and identify possible toxicity signs after using EMLA. Relates one of the first ...
A 67-year-old patient with a personal history of systemic scleroderma and chronic renal failure and who had been in hemodialysis since 2004 presented with an itchy, erythematous, and desquamative ...
Objectives To compare the effect of topical skin anaesthetic agents on the discomfort and anxiety associated with venous cannulation. Design Randomised, double-blind, placebo-controlled, within ...
Alembic Pharmaceuticals Ltd on Tuesday said its wholly-owned arm, Aleor Dermaceuticals Ltd, has received final approval from the US health regulator for its generic version of Lidocaine and Prilocaine ...
Zydus Lifesciences Limited has received final approval from the US Food and Drug Administration (USFDA) to manufacture Lidocaine and Prilocaine Cream USP, 2.5 per cent/2.5 per cent, the company ...
Dermatitis. 2006;17(2):85-87. All patients had positive reactions to prilocaine and negative reactions to lidocaine and therefore had no cross-reactions between the two local anesthetics or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback